← Back

Danish Medicines Agency · Denmark · 2 Oct 2026 · Guidance

Guidance on Complex Clinical Trials and Seasonal Vaccine Trials

AI-generated summary

The Danish Medicines Agency provides guidance on submitting complex clinical trials and seasonal vaccine trials through CTIS. Complex trials may need special handling during initial application and modifications, with details on EU CT numbers, master protocol amendments, safety information, and notifications available in the guidance for non-commercial trials and SMEs. For seasonal vaccine trials where vaccine strains may be unknown at application or updated later, applicants should consult the same guidance section on managing these changes in CTIS.

From Danish Medicines Agency

Please find below separate guidance on complex clinical trials and clinical trials involving seasonal vaccines.

Complex clinical trials may require special handling during the initial application process and when submitting subsequent modifications in CTIS. Guidance on how to submit complex clinical trials and manage matters such as EU CT numbers, amendments to the master protocol, safety information, and notifications can be found in the homepage Guidance for Non-Commercial Clinical Trials and SMEs under the section “Complex Clinical Trials.”

In clinical trials involving seasonal vaccines, the vaccine strains to be used in the trial may not be known at the time of application or may be updated subsequently. Please refer to the Guidance for Non-Commercial Clinical Trials and SMEs under the section “Seasonal Vaccine Trials” for information on how to submit such trials and manage related changes in CTIS.

Excerpt from the official page. The original is authoritative.